Fortis Healthcare Hits Record High on Strong Financial Growth, Joins Nifty Midcap 150

Fortis Healthcare shares surged to an all-time high of ₹976.65 on the BSE in opening trade, up nearly 1% from the previous close. The stock has also been included in the Nifty Midcap 150 index, further boosting investor confidence. The company’s consolidated financials reflect steady growth. For the quarter ending June 2025, revenue rose to ₹2,166.72 crore from ₹1,858.90 crore in June 2024. Net profit surged to ₹263.86 crore compared to ₹173.39 crore a year earlier, with EPS improving from ₹2.20 to ₹3.45. Annual performance also shows a strong uptrend: revenue increased from ₹4,030.12 crore in FY21 to ₹7,782.75 crore in FY25, while net profit jumped from a loss of ₹103.73 crore in FY21 to a profit of ₹797.86 crore in FY25. Key ratios as of March 2025 include EPS ₹10.26, book value per share ₹118.11, and a debt-to-equity ratio of 0.25. The company declared a final dividend of ₹1 per share and announced a board change with Dr. Keith joining as director, replacing Mr. Tomo Nagahiro effective September 9, 2025. Market experts remain bullish, citing robust earnings, strong margins, and inclusion in the Nifty Midcap 150 as key drivers of investor sentiment. #FortisHealthcare #StockMarket #NiftyMidcap150 #EarningsGrowth #Investors #HealthcareStocks #BSE